Xenetic Biosciences Inc
XBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.95M
Close$
$7.48
118.8% upside
Current Fair Value
118.8% upsideUndervalued by 118.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.95 Million |
|---|---|
| Enterprise Value | $-1,397,743.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.58 |
| Beta | 2.22 |
| Outstanding Shares | 2,291,056 |
Return
| Return on Equity | -32.14% |
|---|---|
| Return on Assets | -28.25% |
| Return on Invested Capital | -33.95% |
Valuation & Multiples
| P/E Ratio | -3.23 |
|---|---|
| PEG | 6.53 |
| Price to Sales | 3.42 |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | -0.44 |
| Enterprise Value to EBIT | 0.59 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xenetic Biosciences Inc
2,018 employees